Implementation of Artificial Intelligence–Based Diabetic Retinopathy Screening in a Tertiary Care Hospital in Quebec: Prospective Validation Study

Fares Antaki   ^{1, 2, 3, 4, 5 *} , MDCM ;   Imane Hammana   ^{6 *} , PhD ;   Marie-Catherine Tessier   ² , MSc ;   Andrée Boucher   ⁷ , MD ;   Maud Laurence David Jetté   ⁸ , MPA ;   Catherine Beauchemin   ⁹ , PhD ;   Karim Hammamji   ^{2, 3} , MD ;   Ariel Yuhan Ong   ^{1, 5, 10} , MBChB ;   Marc-André Rhéaume   ^{2, 3} , MD ;   Danny Gauthier   ^{2, 3} , MD ;   Mona Harissi-Dagher   ^{2, 3} , MD ;   Pearse A Keane   ^{1, 5, 11} , MD ;   Alfons Pomp   ^{6, 12} , MD

¹ Institute of Ophthalmology, University College London, London, United Kingdom

² Department of Ophthalmology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada

³ Department of Ophthalmology, Université de Montréal, Montreal, QC, Canada

⁴ The CHUM School of Artificial Intelligence in Healthcare, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada

⁵ Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom

⁶ Health Technology Assessment Unit, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada

⁷ Division of Endocrinology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada

⁸ Direction du soutien à la transformation, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada

⁹ Faculty of Pharmacy, University of Montreal, Montreal, QC, Canada

¹⁰ Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

¹¹ NIHR Moorfields Biomedical Research Centre, London, United Kingdom

¹² Department of Surgery, University of Montréal, Montreal, QC, Canada

*these authors contributed equally